Global Health Update: Key Developments in Abortion Laws, Vaccines, and Genetic Studies

A summary of current health updates includes Iowa's new six-week abortion ban, competition among RSV vaccine makers, pharmaceutical companies' views on Medicare price negotiations, intimate partner violence among adolescent girls, genetic mutations in Parkinson's patients, and more.

Iowa has enforced a ban on abortions after six weeks of pregnancy, becoming the 22nd state to impose such restrictions since the Supreme Court's 2022 ruling on federal abortion rights. Planned Parenthood's legal challenge was dismissed by Iowa's state Supreme Court last month.

RSV vaccine makers Pfizer, GSK, and Moderna are vying for market share as they prepare to report earnings. Investors anticipate updates on company negotiations with pharmacies and their strategies to gain market share, following new U.S. regulatory guidelines.

Pharmaceutical companies such as Bristol Myers Squibb, Johnson & Johnson, AbbVie, and AstraZeneca do not expect a significant impact from the first U.S. Medicare price negotiations, set to take effect in 2026. Their outlooks were discussed during quarterly conference calls.

The WHO's recent study revealed that nearly a quarter of adolescent girls have experienced physical or sexual violence from partners, with the findings prompting calls for increased preventive measures.

A study published in Brain suggests a higher-than-expected rate of gene mutations in Parkinson's disease patients, advocating for broader genetic testing among affected individuals.